A Single-dose, Open-label, Parallel Group, Matched Study Evaluating the Pharmacokinetics of Oral OPC-34712 Tablet in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects
Phase of Trial: Phase I
Latest Information Update: 24 Oct 2015
At a glance
- Drugs Brexpiprazole (Primary)
- Indications Major depressive disorder
- Focus Pharmacokinetics
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 08 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jun 2011 Planned End Date changed from 1 Nov 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.
- 08 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.